Aeon Clinic has established a Dubai location offering intravenous NAD+ and micronutrient protocols under physician supervision, positioning direct bloodstream delivery as a strategy for metabolic optimization and cellular repair. The clinical model integrates medical oversight with targeted nutrient repletion, addressing bioavailability constraints inherent in oral supplementation.
Key Points
- NAD+ IV protocol claims to support DNA repair and metabolic function
- Direct bloodstream delivery bypasses gastrointestinal absorption limitations
- Physician-supervised protocols in medically licensed clinical setting
Longevity Analysis
Intravenous micronutrient delivery addresses a fundamental barrier in nutritional optimization: the digestive system's variable capacity to absorb and transport compounds systemically. By circumventing absorption constraints, IV protocols can achieve circulating concentrations difficult to attain through oral intake alone. NAD+ specifically modulates mitochondrial function and DNA repair mechanisms—processes central to how cells regenerate and maintain energy production across the lifespan. The clinical infrastructure here—physician oversight, baseline assessment, sterile administration—distinguishes this from unmonitored supplementation. Whether such protocols produce measurable improvements in longevity markers or healthspan outcomes requires prospective data; the service reflects growing recognition that substrate availability, not just supplement selection, constrains cellular function.
Original published by Longevity.Technology.